Document Detail


ERBB2 inhibition and heart failure.
MedLine Citation:
PMID:  23190227     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Authors:
Gregory M Cote; Douglas B Sawyer; Bruce A Chabner
Related Documents :
821407 - Inflammatory carcinoma of the breast: a correlation of clinical, radiologic and pathogi...
20664517 - Accelerated partial breast irradiation: potential roles following breast-conserving sur...
20565467 - Oncological and aesthetic considerations of conservational surgery for multifocal/multi...
18705397 - Assessment of surgical treatment in elderly patients with breast cancer.
18656827 - Should patients with barrett's oesophagus be kept under surveillance? the case against.
18431597 - Establishment of cxcr4-small interfering rna retrovirus vector driven by human prostate...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The New England journal of medicine     Volume:  367     ISSN:  1533-4406     ISO Abbreviation:  N. Engl. J. Med.     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-29     Completed Date:  2012-12-12     Revised Date:  2014-03-04    
Medline Journal Info:
Nlm Unique ID:  0255562     Medline TA:  N Engl J Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2150-3     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antibodies, Monoclonal, Humanized / adverse effects*
Antineoplastic Agents / adverse effects*
Biological Markers / analysis
Heart Failure / drug therapy,  etiology*
Humans
Myocardium / metabolism
Neuregulin-1 / analysis,  metabolism,  therapeutic use*
Receptor, erbB-2 / agonists,  antagonists & inhibitors,  metabolism*
Grant Support
ID/Acronym/Agency:
P20 HL101425/HL/NHLBI NIH HHS; R01 HL068144/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Antibodies, Monoclonal, Humanized; 0/Antineoplastic Agents; 0/Biological Markers; 0/Neuregulin-1; EC 2.7.10.1/ERBB2 protein, human; EC 2.7.10.1/Receptor, erbB-2; P188ANX8CK/trastuzumab
Comments/Corrections
Comment In:
N Engl J Med. 2013 Feb 28;368(9):876   [PMID:  23445109 ]
N Engl J Med. 2013 Feb 28;368(9):875-6   [PMID:  23445110 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Case 37-2012.
Next Document:  Multidrug-resistant tuberculosis.